Laura L. Adams

Advisor at Inflammatix

Laura Adams, Special Advisor at the National Academy of Medicine (NAM), provides leadership for the NAM Digital Health and Evidence Mobilization portfolios of the Leadership Consortium. She has expertise in biotechnology, health care innovation, and human-centered care. She serves on the board of Translational Medicine Accelerator (TMA), a Boston-based precision medicine company focusing on patients with recalcitrant and rare diseases; and the Oversight Council for the MA Center for Health Information and Analysis.

Previously, Laura was the founding President and CEO of the Rhode Island Quality Institute (RIQI), RI’s statewide Health Information Exchange. During her time at RIQI, Health Data Management named her one of their 2018 Most Powerful Women in Health IT in the Thought Leader category and Becker’s Hospital Review named her to the 2018 inaugural list of Female Health IT Leaders to Know and to its 2019 list of Women in Health IT to Know. As Catalyst at X4 Health, Laura led the national strategic partnerships for the 3rd Conversation (3C) project (https://www.3rdconversation.org/), helping to reweave humanity into the fabric of healthcare and healing.

Laura chaired the Institute of Medicine’s (IOM) Planning Committee for the “Digital Infrastructure for Population Health and a Learning Healthcare System” initiative. Through her Laura Adams Consulting company, she has delivered conference keynotes in nearly every state in the union and in 13 different countries.

Timeline

  • Advisor

    Current role